Navigation Links
Dainippon Sumitomo Pharma Co., Ltd. and Boston Biomedical, Inc. Enter Strategic Partnership on Anti-Cancer Drugs Targeting Cancer Stem Cells
Date:4/7/2011

OSAKA, Japan and NORWOOD, Mass., April 7, 2011 /PRNewswire/ -- Dainippon Sumitomo Pharma Co., Ltd. ("DSP") and Boston Biomedical, Inc. ("BBI"), today announced that they have signed a Product Option License Agreement for BBI608 for all oncology indications in Japan and exclusive right of negotiation for BBI608 for the United States and Canada.

BBI608 is an orally administered, first-in-class, small molecule anti-cancer drug that targets highly malignant cancer stem cells as well as other heterogeneous cancer cells. In clinical trials to date, BBI608 has shown excellent safety, favorable pharmacokinetics, and encouraging signs of anticancer activity.  BBI608 is under phase I extension clinical studies in colorectal cancer and phase Ib/II trials in multiple solid tumor types.

Under the terms of the agreement, BBI will receive $15million of upfront payment and clinical trial support upon signing.  Based on the outcome of the clinical trials, DSP has the option to acquire exclusive rights for the development and commercialization for BBI608 in Japan. In addition, DSP has an exclusive negotiation right for the United States and Canada for a certain time.  During this option agreement period, DSP will pay a maximum of $55million for part of the development costs of BBI608 and for continuation of the option. Assuming DSP exercise the option for Japan, upon successful clinical development and commercialization of BBI608 in Japan, BBI could receive a maximum of approximately $100million in aggregate, including milestone payments associated with successful development and commercialization, in addition to running royalties.

Masayo Tada, President and chief executive officer of DSP, said, "DSP recognizes oncology as an area with high unmet medical needs and has already spent substantial effort, defining it as a major specialty area. We are delighted to enter into this strategic partnership with Boston Biomedical in the oncology area to d
'/>"/>

SOURCE Boston Biomedical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dainippon Sumitomo Pharma and Intercept Pharmaceuticals Announce Agreement to Develop and Commercialize Obeticholic Acid (INT-747) for Chronic Liver Disease
2. Codexis Signs First Japanese Biocatalysis Collaboration With Dainippon Sumitomo Pharma
3. Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia
4. Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
5. CVS/pharmacy Debuts the "To Your Health" Program in Atlanta Bringing 60 Free Health Screening Events to the Community
6. CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste
7. Fuisz Pharma LLC Develops a New Generation of Oral Solid Dosage Form Shapes That Facilitate Swallowing and Esophageal Transit
8. Harnessing Patients Good Intentions Can Cut 33% of Americas Pharmacy-Related Waste
9. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
10. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
11. ACLJ Gets Win for Pro-Life Pharmacy Owners in Illinois After Lengthy Legal Battle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the addition ... Analysis, Size, Share, Growth, Trends And Forecast, 2013 - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Dental ... order to treat dental impairments, for tooth restoration and ...
(Date:1/15/2014)... 2014  Novation, the leading health care supply chain expertise, ... reseller (VAR) national contracts that expand its portfolio to ... lower costs. These include manufacturer product and service agreements, ... and ongoing IT consulting support. New ...
(Date:1/15/2014)... , January 15, 2014 Shire plc (LSE: SHP, ... Office of Fair Trading (OFT) approval condition to the announced tender ... VPHM).   As a result of the waiver, the ... to complete the tender offer on January 24, 2014 following the ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... 26 HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA), ... Internet Pharmacy Practice Sites(CM) (VIPPS(CM)) accreditation from The National Association of ... pharmacies to be VIPPS accredited in the United States . ... According ...
... online distribution of Agency,s consumer health information , ... SPRING, Md. , May 26 The U.S. Food and Drug Administration announced ... FDA,s consumer health information. , , , ... , , ...
Cached Medicine Technology:HealthWarehouse.com Receives VIPPS Accreditation From The National Association of Boards of Pharmacy 2FDA Announces Collaboration With Drugs.com 2
(Date:4/17/2014)... chronic inflammation in non-cancerous prostate tissue may have nearly ... those with no inflammation, according to results of a ... Kimmel Cancer Center. , The link between persistent inflammation ... high-grade prostate cancer those with a Gleason score ... the most aggressive and rapidly growing prostate cancers. , ...
(Date:4/17/2014)... the April issue of Experimental Biology and ... Drs. Rex Gaskins and Paul Kenis in the ... of the University of Illinois Urbana-Champaign describe their ... reactions underlie a variety of cell functions including ... these crucial roles in regulating normal cellular behavior, ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
(Date:4/17/2014)... 2014-- Colic affects about one in five infants in ... visits during the first several months after birth. Research ... showing promise; however, the April 1, 2014 issue of ... reported on a study, "Probiotics and Infant Colic," concluding ... for infant colic did not reduce crying ...
(Date:4/17/2014)... Spending time online has the potential to ward off ... according to research published online in The ... Sciences . In the article " Internet Use ... States: A Longitudinal Analysis ," the authors report that ... by 33 percent among their study sample. , ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Internet use may cut retirees' depression 2
... Praxis(R) EMR was named,the top EMR in the 2008 ... Physicians, (AAFP) with 93,000 members nationwide., "This is ... makers of Praxis EMR, "Praxis is the only EMR ... it to other EMRs. Templates,turn doctors into technicians, forcing ...
... GREENWICH, Conn., March 4 Oracle Healthcare,Acquisition Corp. ... it has entered into an agreement with Precision ... the Agreement and Plan,of Merger, dated as of ... 2008 and,February 25, 2008 (as amended, the "Merger ...
... WASHINGTON and NEWARK, N.J., March 4 ,Cathedral Healthcare ... States $5.3,million, plus interest, to settle allegations that ... announced today., The settlement resolves allegations that ... Medicare patients in order,to obtain enhanced reimbursement from ...
... of veterinary medicine at Iowa State University, has identified ... disease, Immune-Mediated Retinopathy, or IMR, causes loss of function ... canines. , Grozdanic,s findings are published in the March ... Practice. , IMR is very similar to a previously ...
... New York man was,charged today in federal court with ... Sullivan; Warren T. Bamford, Special,Agent in Charge of the ... Special Agent in Charge of the Department of Health ... Resident,Agent in Charge of the Defense Criminal Investigative Service; ...
... March 4 Secretary of Health Dr.,Calvin B. ... Pediatric,Clinic in Warren to discuss Governor Edward G. ... to the hundreds of thousands of,uninsured adults through ... affordable insurance is critical to help prevent disease,successfully ...
Cached Medicine News:Health News:Template-Free Electronic Medical Record Wins AAFP User Satisfaction Survey. 2Health News:Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting 2Health News:Cathedral Healthcare System to Pay U.S. $5.3 Million to Resolve Allegations Involving Inflated Charges to Obtain Higher Medicare Reimbursement 2Health News:Iowa State University researcher identifies eye disease in canines 2Health News:Thomas Farina, Former Pharmaceutical Company District Manager, Charged With Obstruction of Justice 2Health News:Thomas Farina, Former Pharmaceutical Company District Manager, Charged With Obstruction of Justice 3Health News:Health Secretary Stops in Warren County on Statewide Tour to Call for Action on Health Insurance for All Pennsylvanians 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: